APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Supportive nursing, nutritional and physical activity with a handheld 'app'.
- Who it may be relevant to
- Registry conditions: Allogeneic Disease. Basic parameters: 18 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
People who undergo allogeneic bone marrow transplant for blood cancers receive the highest chemotherapy doses possible that humans can receive and still survive. As a result, they have devastating side effects during the procedure and for many years afterwards. Damage to organs and muscles cause long-lasting physical weakness and the psychological experience is severe enough to be termed 'post traumatic stress disorder' that also lasts for many years. These effects are worsened by the fact that most Canadians live several hours away from treatment and transplant centers, leaving them entirely on their own to manage these difficult long term effects. The APOLLO team will perform a qualitative study to learn the experiences of people undergoing allogeneic bone marrow transplant while they receive access to a supportive care computer 'app' and telephone support from nursing, exercise and nutrition experts. In this way, the APOLLO team will learn the most helpful type and timing of supportive care from those who know best.
Interventions
- Behavioral Supportive nursing, nutritional and physical activity with a handheld 'app'
Supportive nursing, nutritional and physical activity with a handheld 'app'
Primary outcome measures
- Title: Acceptability of a multimodal supportive care [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- eligible for allogeneic transplantation
Exclusion criteria
- none
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Canada · 1 center
- University of Alberta — Edmonton
Publications
- Pituskin E, Foulkes S, Skow RJ, McMurtry T, Kruger C, Bates JE, Lamoureux D, Brandwein J, Lieuw E, Wu C, Zhu N, Wang P, Sawler D, Taparia M, Hamilton M, Comfort-Riddle T, Meyer T, Gyenes GT, Paterson I, Prado CM, Haykowsky MJ, Greiner JG, McNeely ML, Tandon P, Thompson RB. Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation. BMC Cancer. 2 PMID 39875816
Identifiers
NCT: NCT05579678 · HREBA.CC-22-0164